Radar · Industry landscape · India
Life Sciences Landscape of India 2,471 Life Sciences companies in India, in one picture: who is hiring, who is raising money, who founded them, where they are based, what the news is about, which skills employers want and where the research is going. Updated August 2026.
2,471 companies tracked
$3B disclosed funding
290 hiring right now
531 events · 24 months
42,125 news articles · 12 months
Who leads Life Sciences in India Tracks 2,471 Indian life‑sciences firms, highlighting which are hiring, which have recent funding rounds, and the top companies in hiring and financing.
Radar
See all 2,471 Life Sciences companies in India
Filter by funding, headcount, hiring and location, and export the list.
How the Life Sciences ecosystem in India grew, 2016–2025 Shows the number of companies founded each year, with a peak of 191 new firms in 2020 and 50 in 2025.
Companies founded / year
new Life Sciences companies in India
2016: 128 2017: 141 2018: 148 2019: 164 2020: 191 2021: 176 2022: 143 2023: 127 2024: 124 2025: 50 2016 2025
peak 191 in 2020
Companies raising / year
with a disclosed round that year
2016 2025
peak 107 in 2021
Disclosed funding / year
sum of disclosed rounds (USD)
2016: 44,733,258 2017: 112,577,989 2018: 211,919,806 2019: 101,444,548 2020: 707,922,211 2021: 224,858,552 2022: 421,160,809 2023: 175,949,522 2024: 273,888,693 2025: 231,259,428 2016 2025
peak $707.9M in 2020
Where Life Sciences companies in India are based → Hub 01
Bengaluru
403 Life Sciences companies
25% of the Life Sciences companies across these hubs
403 companies
$1B disclosed funding
56 hiring now
Hub 02
Delhi
242 Life Sciences companies
15% of the Life Sciences companies across these hubs
242 companies
$27.5M disclosed funding
22 hiring now
Hub 03
Mumbai
236 Life Sciences companies
15% of the Life Sciences companies across these hubs
236 companies
$938.8M disclosed funding
29 hiring now
Hub 04
Hyderabad
235 Life Sciences companies
15% of the Life Sciences companies across these hubs
235 companies
$177.5M disclosed funding
36 hiring now
Hub 05
Chennai
138 Life Sciences companies
9% of the Life Sciences companies across these hubs
138 companies
$140.1M disclosed funding
19 hiring now
Hub 06
Pune
133 Life Sciences companies
8% of the Life Sciences companies across these hubs
133 companies
$59.4M disclosed funding
16 hiring now
Hub 07
Ahmedabad
126 Life Sciences companies
8% of the Life Sciences companies across these hubs
126 companies
$26.1M disclosed funding
22 hiring now
Hub 08
Gurugram
83 Life Sciences companies
5% of the Life Sciences companies across these hubs
83 companies
$59.8M disclosed funding
17 hiring now
The Life Sciences market map of India: what these companies actually do Breaks down product sub‑categories and revenue models, noting the largest groups such as enterprise tech (1,629 firms) and the most common sales approaches like e‑commerce product sales (1,360).
Enterprise Tech 1,629 companies · $2B raised · 207 hiring Medical Devices 660 companies · $966.3M raised · 102 hiring Consumer Digital 635 companies · $1.1B raised · 74 hiring Healthtech 479 companies · $455.9M raised · 59 hiring Nutritional Formula 380 companies · $321.9M raised · 40 hiring Enterprise Software 340 companies · $439.6M raised · 42 hiring Deep Tech 305 companies · $802.9M raised · 47 hiring Biopharmaceuticals 180 companies · $357.5M raised · 18 hiring SaaS 179 companies · $208.1M raised · 23 hiring Healthtech SaaS 144 companies · $134.9M raised · 16 hiring In Vitro Diagnostics 139 companies · $223.3M raised · 14 hiring Food as Medicine 117 companies · $77.2M raised · 14 hiring Monetization
How Life Sciences companies make money How many companies earn revenue each way. Plenty use more than one model, so the counts add up to more than the sector.
E-Commerce - Product 1,360
Physical Commerce 1,086
Subscription 541
Fee-For-Service 388
Commission on Transaction 84
Advertising 70
E-Commerce - Service 57
Sponsorship 8
Funding, M&A and the deals moving Life Sciences in India Counts 531 corporate events in the past two years, including 158 funding rounds, 103 mergers and acquisitions, and 81 earnings releases.
Funding 158 M&A 103 Earnings 81 Leadership 53 Contracts 26 Capital 24 Assets 18 IPO 16 Announcement 13 Regulatory 10
M&A Parexel has acquired pharmaceutical operations software vendor Vitrana. 2026-05-01 M&A Thermo Fisher Scientific said it has signed a definitive agreement to sell its microbiology business to Astorg, a pan-European private equity firm, for consideration of approximately $1.075 billion. 2026-04-27 M&A Hindustan Unilever’s acquisition of the residual 49% stake in plant-based nutrition brand OZiva, valuing the D2C brand at about ₹1,682 crore. 2026-04-20 M&A Nykaa has already acquired brands like Nudge Wellness and Dot & Key skincare to enhance its portfolio in the beauty retail space. 2026-04-06 Funding "Fullife Healthcare raised $31.62 million." 2026-03-30 M&A USV Private Ltd acquired around a 79% stake in nutraceutical firm Wellbeing Nutrition in an all-cash deal valuing the company at ₹1,583 crore in February. 2026-03-25 M&A The acquisition has been executed via a Business Transfer Agreement (BTA), marking Eris Lifesciences’ strategic expansion into the growing probiotics and microbiome-based therapeutics segment. 2026-03-23 Funding Robotic neuro-rehabilitation startup, Rymo Technologies, raised over ₹10 crore in a seed round led by IAN Angel Fund. 2026-03-19 M&A Kedaara Capital, the homegrown private equity firm ... is preparing to sell Universal NutriScience (UNS). 2026-03-10 Funding SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII ), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that on March 6, 2026, the Company completed a private placement of its common stock (the “Private Placement”) which generated approximately $18.6 million in gross proceeds, before deducting offering expenses. 2026-03-09 Mergers and acquisitions Deals from the last 24 months where a Life Sciences company in India was the buyer or the one bought, newest first. “Undisclosed” means the price was never published — not that the deal was worth nothing.
Who is listing, hiring leaders, launching and winning work Details notable corporate actions such as IPO filings, leadership changes, product launches, and contract wins.
IPO pipeline
12 companies listed or filing · last 24 months
Leadership moves
11 tracked people moves · last 12 months
Contract wins
16 customer wins · last 24 months
Earnings pulse
companies reporting results · last 24 months
18 companies reporting87 company-quarters trackedbeat 23 miss 6 in line 0
Half of these companies grew revenue faster than +6.0% , half slower.
Who is building Life Sciences in India Profiles 2,221 founders and CEOs across 1,595 firms, noting frequent alma maters like IIT Bombay (28) and prior employers such as Microsoft (6).
Founders and chief executives 12 of 2,221, from the best-funded companies on this page
→ CEO & President
Dig Howitt
Ex-Organic Response, Boral, BCG · University of Sydney BE 1990, Stanford University Graduate School of Business MBA 1996
Co-Founder & Group CEO
Mahesh Pratapneni
Founder Emerge Ventures, Co-Founder GenomeAsia 100K. IIT Madras B.Tech 1993, IIM Calcutta MBA 1995
Co-Founder & CEO
Siddharth Shah
repeat founder Co-Founder-PharmEasy, API Holdings · Ex-Co-Founder-DIAL HEALTH CARE INDIA · IIM Ahmedabad MBA 2012
Ex-Myntra, Mu Sigma · IIT Madras BTech 2008, Indian School of Business MBA 2014
University of Leeds BS 2008
Co-Founder & President
Chirag Shah
repeat founder CEO Capp Aps, Neuation Technologies, Fine Care Biosystems. L M College of Pharmacy BPharm 1989
repeat founder Ex-Barclays, American Express, J.P. Morgan. IIT Varanasi BTech 2009, SGH Warsaw School of Economics 2011, Management Development Institute…
CEO & Managing Director
Mayura Jain
Ex-Shasun · Anna University Chennai BTech 2000, Northwestern University MSc 2001
Co-Founder & CEO
Tathagato Dastidar
Ex-Tribune, American Express, Ago Synthesis · IIT Kharagpur BTech 2000, PhD 2006
Co-Founder & CEO & Director
Tuhin Bhowmick
Co-Founder & CEO-Pandorum MSU Baroda MSC 2005, IISc PhD 2012
Co-Founder & CEO
Anand Anandkumar
Ex-Cellworks Research India, Magma Design Automation India, Monterey Design Systems, Cadence Design Systems. Anna University Chennai BE 1986…
Co-Founder
Sreeram Venkitaraman
Goapptiv, ex-Health Care Industry, ex-Pfizer, Indian Institute of Technology, Bombay, 2018
Where the founders studied
alma mater on record for 282 of 2,221 founders
IIT Bombay 28
BITS Pilani 27
IIT Delhi 22
IIT Kharagpur 20
Indian School of Business 19
IIT Madras 15
IIT Kanpur 13
IIT Roorkee 13
Where they worked before
a previous employer on record for 24 of 2,221 founders
Microsoft 6
McKinsey 4
Amazon 3
Flipkart 3
Myntra 2
Boston Consulting Group 2
Goldman Sachs 2
Zoho 1
Founders flagged as repeat founders
of 2,002 founders with a profile on this page
24
carry a repeat-founder flag
flagged as repeat founders 24 no repeat-founder flag 1,978 Radar
Look up the people behind Life Sciences companies in India
Search founders, executives and operators by company, role and location.
Who funds Life Sciences in India Records 1,148 funding rounds since 2016 from 3,217 investors, with a typical round size of $300 k.
Stage mix · rounds since 2016
Seed & Angel 753
Series A–B 151
Series C+ / PE 25
Grants, debt & other 219
The typical round is $300k — half were bigger, half smaller.
The biggest Life Sciences funding rounds in India Highlights the largest disclosed round—Molbio Diagnostics' $85 M Series C—and lists ten other major recent rounds.
Company Round Size When Backers Molbio Diagnostics Series C $85M Sep 2022 Temasek , Motilal Oswal Financial Services Accumax Series C $68M May 2022 Moringa , Gandaraditya Chola , Creador +1 more Redcliffe Genetics Series B $61M May 2022 LeapFrog Investments , HealthQuad , Schroders +4 more MedGenome Series D $55M Apr 2020 LeapFrog Investments , Sofina , Peak XV Partners MedGenome Series D $50M Aug 2022 Novo Holdings , Sofina , LeapFrog MedGenome Series E $47.5M Jul 2025 Maj Invest , Novo Holdings , Sofina MedGenome Series C $40M Mar 2018 HDFC , HDFC Life , HDFC Mutual Fund +2 more S3V Vascular Technologies Series B $36.2M Mar 2024 Anil Manibhai Naik , Vipul Chandra , RNG Family Private Trust +23 more Fullife Series D $32M Mar 2026 Elev8 , Orchid Asia Group LifeCell Series B $30.5M Sep 2021 Orbimed
Venture round sizes · 2023–2025
<$1M 150
$1–10M 78
$10–50M 19
$50–250M 0
>$250M 0
247 venture rounds with a disclosed amount in the window.
Fresh cheques · last 6 months
What the news says about Life Sciences in India Indexes 42,125 news articles from the last year, with most coverage on vaccine development, drug pricing, and generic drug trends.
News volume
Life Sciences coverage across India · articles per quarter
2021Q2: 18,615 2021Q3: 11,843 2021Q4: 8,934 2022Q1: 9,602 2022Q2: 8,953 2022Q3: 9,184 2022Q4: 10,410 2023Q1: 10,556 2023Q2: 9,701 2023Q3: 9,959 2023Q4: 9,069 2024Q1: 9,204 2024Q2: 9,449 2024Q3: 10,771 2024Q4: 11,824 2025Q1: 13,334 2025Q2: 9,173 2025Q3: 10,740 2025Q4: 10,171 2026Q1: 11,560 2021Q2 2026Q1
peak 18,615 in 2021Q2 · 42,125 articles in the last 12 tracked months
Tone of coverage
share of articles by dominant sentiment (positive / neutral / negative )
2021 2023 2025
Positive-tone share moved 68% → 77%, negative 30% → 21% across 2021–2025.
What the coverage is about The subjects that dominate Life Sciences news in India. The arrow shows whether each one is being written about more or less than a year ago.
Covid-19 vaccine development and efficacy trials 11,532 →-7% Drug pricing and reimbursement strategies 7,956 ▲+38% Vaccine research and production methods 7,202 ▲+14% Generic drug development and market trends 6,873 ▲+47% Covid-19 vaccination campaigns and rollout strategies 5,668 ▲+33% Pharmaceutical supply chain management 5,449 ▲+73% Pharmaceutical marketing and sales strategies 3,945 ▲+49% Economy news: central bank interest rate decisions 3,051 ▼-17% Economy news: inflation rate analysis 2,998 ▼-23% Pharmaceutical manufacturing techniques 2,996 ▲+127% Most-covered companies · last 12 months
98 Life Sciences companies here were named in the news over this period.
Prism
Watch Life Sciences coverage in India as it happens
Prism follows these subjects story by story — which companies are named, what is said about them and how the tone moves.
Momentum
The words getting louder — and quieter Which terms are showing up in more stories than a year ago, and which are fading. The percentage is the change in how many articles mention them.
generic drug approval+60% drug distribution+50% innovator drug patents+57% drug patent exclusivity+54% drug safety monitoring+95% medication patent litigation+57% regulatory inspection+63% drug repurposing ai+53% diagnostic biotechnology+70% commodity futures+198%
core inflation rate-41% inflation analysis-37% headline inflation-37% test cricket-79% stock indices-57%
The pressures the press keeps returning to Three recurring angles in India Life Sciences coverage, and whether each is getting more attention year on year (through 2025).
Regulatory Risk → flat
68,217 articles touch this dimension · 59.0% critical tone
2021 2025
signals: monetary stance shift, core inflation rate, monetary easing
Funding Momentum → flat
14,019 articles touch this dimension · 52.0% critical tone
2021 2025
signals: pre-ipo valuation, ipo prospectus, ipo pricing
Growth ▲ rising
46,494 articles touch this dimension · 42.0% critical tone
2021 2025
signals: monetary stance shift, core inflation rate, monetary easing
Life Sciences jobs in India: who is hiring and what they ask for Aggregates 2,150 job postings from 155 firms, showing top skills like Python and SQL and a median advertised salary of $9 k per year.
2,150 postings · last 12 months
2,657 postings tracked overall
155 employers advertising
$9k median advertised salary/yr (n=149)
Demand
The Skills Employers Ask For What Life Sciences employers in India put in their job ads. The bar is how many postings ask for it; the arrow shows whether demand grew or shrank against the year before.
python 304 ▲ sql 285 ▲ project management 224 ▲ aws 156 ▲ java 143 ▲ sales 121 ▲ excel 113 ▲ git 112 ▲ communication 112 ▲ data analysis 106 ▲ What level are these roles?
Entry 44
Intern 52
Senior 457
Lead 184
Manager 656
Most advertised titles
Area Sales Manager 32 Program Manager 32 Sales Manager 32 Customer Service Representative 29 Sales Specialist 23 Customer Service Representative Ii 21 What Life Sciences research in India is working on Summarizes 2,919 India‑affiliated academic papers, classifying 1,802 as identifying opportunities, 388 as noting common problems, and 86 as issuing cautions.
How this field talks about itself
India-affiliated Life Sciences papers (gold) against all published research (grey)
Promising 49.0% · 37.5% 1.3×
Descriptive 19.3% · 17.6% ≈ par
Breakthrough 12.8% · 26.1% 0.5×
Problem-identifying 12.6% · 9.8% 1.3×
Cautionary 2.9% · 4.2% 0.7×
Comparative 2.7% · 3.9% 0.7×
India-affiliated Life Sciences literature runs 1.3× more “promising” than science at large (49.0% vs 37.5% baseline).
How the work is done
Empirical 45.1%
Reviews 40.9%
Methods-led 10.4%
Position pieces 3.2%
Theoretical 0.4%
How the research reads
93% positive · 3% neutral · 4% negative , across 2,919 papers.
The institutions doing the work · India
Cancer Institute 7k University of Allahabad 6k Aligarh Muslim University 6k International Centre for Genetic Engineering and Biotechnology 5k Birla Institute of Technology, Mesra 5k International Crops Research Institute for the Semi-Arid Tropics 5k ranked by how often their work is cited
Leading researchers · India-affiliated work
Archana Panche · A D Diwan · Sheela Chandra · Kanti Bhooshan Pandey · Syed Ibrahim Rizvi · J. E. Till · E. A. McCulloch · Rajeev K. Varshney
The most-cited breakthroughs
Biomedical photoacoustic imaging · 2k cites Engineering circular RNA for potent and stable translation in eukaryotic cells · 794 cites Loop mediated isothermal amplification (LAMP): a new generation of innovative gene amplification technique; perspectives in clinical diagnosis of infe · 734 cites Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity · 614 cites Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation · 595 cites Common problems researchers identify 363 papers · 7 recurring themes
→ Problems · theme 01
Food Safety and Security
65 papers · 17.9% of this block
2022: 448 of every 10,000 papers on this subject 2023: 423 of every 10,000 papers on this subject 2024: 328 of every 10,000 papers on this subject 2025: 339 of every 10,000 papers on this subject 2022: 448 of every 10,000 papers on this subject 2023: 423 of every 10,000 papers on this subject 2024: 328 of every 10,000 papers on this subject 2025: 339 of every 10,000 papers on this subject ▼ -24% share 2022→2025 share of research on this subject Researchers highlight risks in food safety, processing, and population nutrition, emphasizing need for sustainable management.
Food safety · Population · Food processing · Food security
“Aflatoxins: A Global Concern for Food Safety, Human Health and Their Management”
Problems · theme 02
Medicinal Plant Challenges
61 papers · 16.8% of this block
2022: 156 of every 10,000 papers on this subject 2023: 149 of every 10,000 papers on this subject 2024: 148 of every 10,000 papers on this subject 2025: 178 of every 10,000 papers on this subject 2022: 156 of every 10,000 papers on this subject 2023: 149 of every 10,000 papers on this subject 2024: 148 of every 10,000 papers on this subject 2025: 178 of every 10,000 papers on this subject ▲ +14% share 2022→2025 share of research on this subject Papers discuss difficulties in replicating phytochemical extraction and drug development from medicinal plants.
Medicinal plants · Drug · Phytochemical · Replication
“Significance of Antioxidant Potential of Plants and its Relevance to Therapeutic Applications”
Problems · theme 03
Biomass and Biofuel Barriers
58 papers · 16.0% of this block
2022: 50 of every 10,000 papers on this subject 2023: 48 of every 10,000 papers on this subject 2024: 50 of every 10,000 papers on this subject 2025: 53 of every 10,000 papers on this subject 2022: 50 of every 10,000 papers on this subject 2023: 48 of every 10,000 papers on this subject 2024: 50 of every 10,000 papers on this subject 2025: 53 of every 10,000 papers on this subject ▲ +8% share 2022→2025 share of research on this subject Studies point to technical hurdles in bioprocessing, synthetic biology, and sustainable biofuel production.
Biomass · Bioprocess · Biofuel · Synthetic biology
“Antimicrobial active packaging with biopolymers and natural extracts: sustainable solutions and technological challenges”
Problems · theme 04
Crop Genetics and Traits
55 papers · 15.2% of this block
2022: 1,635 of every 10,000 papers on this subject 2023: 1,663 of every 10,000 papers on this subject 2024: 1,795 of every 10,000 papers on this subject 2025: 1,993 of every 10,000 papers on this subject 2022: 1,635 of every 10,000 papers on this subject 2023: 1,663 of every 10,000 papers on this subject 2024: 1,795 of every 10,000 papers on this subject 2025: 1,993 of every 10,000 papers on this subject ▲ +22% share 2022→2025 share of research on this subject Authors note constraints in germplasm improvement, trait stability, and disease impact on yields.
Crop · Agriculture · Germplasm · Trait
“Disease Impact on Wheat Yield Potential and Prospects of Genetic Control”
Problems · theme 05
Antibiotic Resistance Concerns
49 papers · 13.5% of this block
2022: 882 of every 10,000 papers on this subject 2023: 835 of every 10,000 papers on this subject 2024: 913 of every 10,000 papers on this subject 2025: 969 of every 10,000 papers on this subject 2022: 882 of every 10,000 papers on this subject 2023: 835 of every 10,000 papers on this subject 2024: 913 of every 10,000 papers on this subject 2025: 969 of every 10,000 papers on this subject ▲ +10% share 2022→2025 share of research on this subject Research flags rising antimicrobial resistance and the need for new defensive strategies.
Antibiotic resistance · Antibiotics · Antimicrobial · Resistance
“Antimicrobial Resistance”
Problems · theme 06
Sustainable Agriculture Issues
42 papers · 11.6% of this block
2022: 1,509 of every 10,000 papers on this subject 2023: 1,556 of every 10,000 papers on this subject 2024: 1,735 of every 10,000 papers on this subject 2025: 1,958 of every 10,000 papers on this subject 2022: 1,509 of every 10,000 papers on this subject 2023: 1,556 of every 10,000 papers on this subject 2024: 1,735 of every 10,000 papers on this subject 2025: 1,958 of every 10,000 papers on this subject ▲ +30% share 2022→2025 share of research on this subject Works identify challenges in applying nanotechnology and other methods for long‑term food security.
Agriculture · Food security · Sustainability · Sustainable agriculture
“Nanotechnology in Sustainable Agriculture: Recent Developments, Challenges, and Perspectives”
Problems · theme 07
Abiotic Stress in Plants
33 papers · 9.1% of this block
2022: 103 of every 10,000 papers on this subject 2023: 88 of every 10,000 papers on this subject 2024: 81 of every 10,000 papers on this subject 2025: 79 of every 10,000 papers on this subject 2022: 103 of every 10,000 papers on this subject 2023: 88 of every 10,000 papers on this subject 2024: 81 of every 10,000 papers on this subject 2025: 79 of every 10,000 papers on this subject ▼ -23% share 2022→2025 share of research on this subject Papers examine how abiotic factors and rhizosphere interactions affect plant resilience.
Abiotic stress · Abiotic component · Rhizosphere · Gut flora
“Salicylic acid-induced abiotic stress tolerance and underlying mechanisms in plants”
Cautions 80 papers · 4 recurring themes
→ Cautions · theme 01
Caution on Antimicrobial Strategies
29 papers · 36.2% of this block
2022: 506 of every 10,000 papers on this subject 2023: 490 of every 10,000 papers on this subject 2024: 538 of every 10,000 papers on this subject 2025: 634 of every 10,000 papers on this subject 2022: 506 of every 10,000 papers on this subject 2023: 490 of every 10,000 papers on this subject 2024: 538 of every 10,000 papers on this subject 2025: 634 of every 10,000 papers on this subject ▲ +25% share 2022→2025 share of research on this subject Authors urge careful evaluation of new antimicrobial and antifungal approaches before widespread use.
Antimicrobial · Antibiotic resistance · Resistance · Antifungal
“Postbiotics-parabiotics: the new horizons in microbial biotherapy and functional foods”
Cautions · theme 02
Nutraceutical Health Risks
26 papers · 32.5% of this block
2022: 182 of every 10,000 papers on this subject 2023: 190 of every 10,000 papers on this subject 2024: 222 of every 10,000 papers on this subject 2025: 283 of every 10,000 papers on this subject 2022: 182 of every 10,000 papers on this subject 2023: 190 of every 10,000 papers on this subject 2024: 222 of every 10,000 papers on this subject 2025: 283 of every 10,000 papers on this subject ▲ +56% share 2022→2025 share of research on this subject Studies caution about uncertain health benefits and shelf‑life issues of nutraceuticals.
Nutraceutical · Human health · Health benefits · Shelf life
“Advances in Edible Coatings for Fresh Fruits and Vegetables: A Review”
Cautions · theme 03
Genotoxicity and Oxidative Stress
20 papers · 25.0% of this block
2022: 193 of every 10,000 papers on this subject 2023: 214 of every 10,000 papers on this subject 2024: 156 of every 10,000 papers on this subject 2025: 153 of every 10,000 papers on this subject 2022: 193 of every 10,000 papers on this subject 2023: 214 of every 10,000 papers on this subject 2024: 156 of every 10,000 papers on this subject 2025: 153 of every 10,000 papers on this subject ▼ -21% share 2022→2025 share of research on this subject Research warns of DNA damage and oxidative stress linked to certain interventions.
DNA damage · Trait · Oxidative stress · Genotype
“Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies”
Cautions · theme 04
Methodological Uncertainties
5 papers · 6.2% of this block
Papers highlight gaps in analytical methods and stress response interpretations.
“Analytical Methods for Identification and Quantification of Quinoa Saponins: A Review”
Opportunities 1,738 papers · 7 recurring themes
→ Opportunities · theme 01
Gene Regulation for Cancer Therapy
372 papers · 21.4% of this block
2022: 2,552 of every 10,000 papers on this subject 2023: 2,558 of every 10,000 papers on this subject 2024: 2,224 of every 10,000 papers on this subject 2025: 1,755 of every 10,000 papers on this subject 2022: 2,552 of every 10,000 papers on this subject 2023: 2,558 of every 10,000 papers on this subject 2024: 2,224 of every 10,000 papers on this subject 2025: 1,755 of every 10,000 papers on this subject ▼ -31% share 2022→2025 share of research on this subject Investigations explore how modulating gene expression can trigger apoptosis and cytotoxic effects.
Downregulation and upregulation · Apoptosis · Gene · Cytotoxicity
“Apoptotic and Anti-Proliferative Potential of Spirulina platensis Methanolic Extract Against the Human Breast Cancer Cell Line MDA-MB-231: A”
Opportunities · theme 02
Microbial Biopesticides
254 papers · 14.6% of this block
2022: 521 of every 10,000 papers on this subject 2023: 505 of every 10,000 papers on this subject 2024: 550 of every 10,000 papers on this subject 2025: 646 of every 10,000 papers on this subject 2022: 521 of every 10,000 papers on this subject 2023: 505 of every 10,000 papers on this subject 2024: 550 of every 10,000 papers on this subject 2025: 646 of every 10,000 papers on this subject ▲ +24% share 2022→2025 share of research on this subject Research shows promise in using microbes and their metabolites to control plant diseases.
Antimicrobial · Fungicide · Antibiotic resistance · Biological pest control
“Harnessing secondary metabolites of endophytic microbes: a next-generation biopesticide for crop disease management”
Opportunities · theme 03
Fermented Feed Enhancements
252 papers · 14.5% of this block
2022: 128 of every 10,000 papers on this subject 2023: 120 of every 10,000 papers on this subject 2024: 117 of every 10,000 papers on this subject 2025: 128 of every 10,000 papers on this subject 2022: 128 of every 10,000 papers on this subject 2023: 120 of every 10,000 papers on this subject 2024: 117 of every 10,000 papers on this subject 2025: 128 of every 10,000 papers on this subject → -0% share 2022→2025 share of research on this subject Studies reveal benefits of fermented feed ingredients for animal growth and nutrient utilization.
Feed conversion ratio · Broiler · Nutrient · Fermentation
“Effect of Dietary Supplementation of Mushroom (Agaricus bisporus) Fruiting Body Waste Powder on Growth Performance, Nutrient Utilization and”
Opportunities · theme 04
Genomics‑Driven Crop Resilience
232 papers · 13.3% of this block
2022: 1,659 of every 10,000 papers on this subject 2023: 1,678 of every 10,000 papers on this subject 2024: 1,809 of every 10,000 papers on this subject 2025: 2,007 of every 10,000 papers on this subject 2022: 1,659 of every 10,000 papers on this subject 2023: 1,678 of every 10,000 papers on this subject 2024: 1,809 of every 10,000 papers on this subject 2025: 2,007 of every 10,000 papers on this subject ▲ +21% share 2022→2025 share of research on this subject Works focus on integrating genomics and breeding to improve drought tolerance and food security.
Agriculture · Crop · Abiotic stress · Food security
“Integrated genomics, physiology and breeding approaches for improving drought tolerance in crops”
Opportunities · theme 05
Sustainable Biomass Utilization
223 papers · 12.8% of this block
2022: 228 of every 10,000 papers on this subject 2023: 250 of every 10,000 papers on this subject 2024: 310 of every 10,000 papers on this subject 2025: 433 of every 10,000 papers on this subject 2022: 228 of every 10,000 papers on this subject 2023: 250 of every 10,000 papers on this subject 2024: 310 of every 10,000 papers on this subject 2025: 433 of every 10,000 papers on this subject ▲ +90% share 2022→2025 share of research on this subject Papers discuss green synthesis and valorization of agri‑food by‑products for biofuel and biotech.
Sustainability · Production · Biomass · Biofuel
“Advances in green synthesis of nanoparticles for biomedical applications: Antimicrobial, antiviral, and cancer therapies”
Opportunities · theme 06
Genetic Diversity for Yield
222 papers · 12.8% of this block
2022: 66 of every 10,000 papers on this subject 2023: 58 of every 10,000 papers on this subject 2024: 52 of every 10,000 papers on this subject 2025: 60 of every 10,000 papers on this subject 2022: 66 of every 10,000 papers on this subject 2023: 58 of every 10,000 papers on this subject 2024: 52 of every 10,000 papers on this subject 2025: 60 of every 10,000 papers on this subject ▼ -8% share 2022→2025 share of research on this subject Research emphasizes leveraging germplasm variability to boost crop productivity.
Heritability · Germplasm · Genetic diversity · Yield
“Assessment of Genetic Variability for Yield-Related Traits in Lentil (Lens culinaris Medik.) Germplasms”
Opportunities · theme 07
Phytochemicals for Health
183 papers · 10.5% of this block
2022: 69 of every 10,000 papers on this subject 2023: 64 of every 10,000 papers on this subject 2024: 60 of every 10,000 papers on this subject 2025: 88 of every 10,000 papers on this subject 2022: 69 of every 10,000 papers on this subject 2023: 64 of every 10,000 papers on this subject 2024: 60 of every 10,000 papers on this subject 2025: 88 of every 10,000 papers on this subject ▲ +28% share 2022→2025 share of research on this subject Studies highlight medicinal plants and nutraceuticals as sources of health‑promoting compounds.
Phytochemical · Medicinal plants · Nutraceutical · Health benefits
“Phytochemistry, pharmacology, and traditional uses of beverage plants with dietary hormetic potential for human health”
Which of these themes are growing fastest Problems
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining share losing share
Sustainable Agriculture Issues ▲+30%
Crop Genetics and Traits ▲+22%
Medicinal Plant Challenges ▲+14%
Antibiotic Resistance Concerns ▲+10%
Biomass and Biofuel Barriers ▲+8%
Abiotic Stress in Plants ▼-23%
Food Safety and Security ▼-24%
Cautions
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining share losing share
Nutraceutical Health Risks ▲+56%
Caution on Antimicrobial Strategies ▲+25%
Genotoxicity and Oxidative Stress ▼-21%
Opportunities
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining share losing share
Sustainable Biomass Utilization ▲+90%
Phytochemicals for Health ▲+28%
Microbial Biopesticides ▲+24%
Genomics‑Driven Crop Resilience ▲+21%
Fermented Feed Enhancements ▼-0%
Genetic Diversity for Yield ▼-8%
Gene Regulation for Cancer Therapy ▼-31%
Prism
Go deeper on Life Sciences research and innovation
Research themes, patent activity and the companies commercialising them, in one place.
More landscapes
Keep going
Track Life Sciences in India beyond this page
Radar finds and filters the companies. Prism watches what is being said about them.
About this data: built from Fliar's company, founder, funding, hiring, jobs, news and research trackers, covering India. Counts are of companies we track, not of every company that exists. Updated August 2026.
Contact details
Reach this founder through Fliar Radar
Direct contact details for the people on this page are held in Fliar Radar, behind its own access controls.